InvestorsHub Logo

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
radly Free
07/29/20 7:35 PM
profile icon
radly Free
07/28/20 11:26 AM
profile icon
invent4 Free
07/24/20 12:46 PM
profile icon
Swing Away Free
07/23/20 7:32 PM
profile icon
invent4 Free
07/23/20 4:14 PM
profile icon
Swing Away Free
07/22/20 2:19 PM
profile icon
greaseball Free
07/22/20 1:59 PM
profile icon
Swing Away Free
07/20/20 3:31 PM
profile icon
Swing Away Free
06/19/20 7:10 AM
profile icon
Swing Away Free
06/07/20 9:11 AM
profile icon
radly Free
06/01/20 11:35 AM
profile icon
radly Free
05/11/20 11:59 AM
profile icon
Swing Away Free
05/08/20 6:53 PM
profile icon
radly Free
04/29/20 12:25 PM
profile icon
radly Free
04/23/20 4:48 PM
profile icon
radly Free
04/23/20 2:04 PM
profile icon
radly Free
04/02/20 1:02 PM
profile icon
radly Free
03/25/20 2:31 PM
profile icon
radly Free
03/13/20 10:32 PM
profile icon
radly Free
03/11/20 10:49 PM
profile icon
radly Free
03/06/20 9:29 PM
profile icon
Swing Away Free
03/04/20 8:29 AM
profile icon
radly Free
03/03/20 10:24 PM
profile icon
radly Free
02/19/20 9:15 PM
profile icon
radly Free
02/12/20 5:35 PM

PHARMA MAR (PHMMF) RSS Feed

Followers
1
Posters
4
Posts (Today)
0
Posts (Total)
53
Created
06/24/16
Type
Free
Moderators
Pharma Mar SA is a Spain-based company engaged in the bio therapeutic drugs manufacture. The Company focuses on research, development and marketing of bio-active principles, primarily from marine origin, for application in human diseases treatment, including antitumour, antiviral and immunomodulation, as well as tropical diseases areas. It manufactures and sells Yondelis, a synthetically modified antitumor agent, which is derived from sea squirts and is implemented in the treatment of soft tissue sarcomas and relapsed ovarian cancer. Furthermore, the Company's products pipeline comprises drug candidates and agents for cancer treatment, such as Aplidin, PM01183 and PM060184. The Company operates through subsidiaries in Italy, Germany, France, and the United States, among others.
Volume:
Day Range:
Last Trade Time:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
PHMMF Latest News
  • No Recent News Available for this company!
New Post